Abstract There is little evidence concerning the biosynthetic pathways for cyclic diarylheptanoids. We previously demonstrated that the cyclic diarylheptanoids myricanol and myricanone were biologically synthesized from two molecules of 4-coumaric acid by the feeding of 4-[8,9-13 C 2 ]coumaric acid to young shoots of Myrica rubra. In the present study, using a 13 C-labeled compound, we revealed that two molecules of 3-(4-hydroxyphenyl)propionic acid could also be a biosynthetic precursor of myricanol in M. rubra. These results indicated that both 4-coumaric acid and its dihydro-derivative were incorporated into myricanol.
Introduction
Cyclic diarylheptanoids, myricanol (I) and myricanone (II), are two of the major components in Myrica rubra Sieb. et S. Kawai (*) · K. Nakata · H. Ichizawa · T. Nishida Laboratory of Forest Microbiology and Biochemistry, Department of Environment and Forest Resources Science, Faculty of Agriculture, Shizuoka University, Ohya, Suruga-ku, Shizuoka 422-8529, Japan Tel. +81-54-238-4851; Fax +81-54-238-4851 e-mail: skawai@agr.shizuoka.ac.jp Part of this report was presented at the 52nd lignin symposium, Utsunomiya, Japan, November 2007 Zucc., 1, 2 and are reported to have antitumor-promoting effects 3 and to exhibit antiandrogen activities. 4 The bark of M. rubra was also used as an astringent, antidote, and antidiarrheal in Japanese folk medicine and has been used externally for burns and skin diseases in Chinese traditional medicine.
Diarylheptanoids comprise a class of natural products based on 1,7-diphenylheptane and have been isolated from Myricaceae, Betulaceae, Zingiberaceae, and Aceraceae plants. 5, 6 The biosynthesis of diarylheptanoids, especially phenylphenalenone derivatives, [7] [8] [9] [10] [11] has been investigated, and two molecules of 4-coumaroyl-CoA and one of malonylCoA are reported to be concerned with the formation of their skeleton. However, there is little knowledge about the biosynthetic pathways for cyclic diarylheptanoids.
Our recent report on M. rubra young shoots fed with 4- [8, [9] [10] [11] [12] [13] C 2 ]coumaric acid ( [8, [9] [10] [11] [12] [13] C 2 ]-III) revealed, through mass and 13 C-nuclear magnetic resonance (NMR) spectrometric analyses, that myricanol (I) and myricanone (II) were derived from two molecules of 4-coumaric acid (III). 12 In particular, the 13 C-NMR analyses of myricanol (I) isolated after administration of 4-[8,9-13 C 2 ]coumaric acid ( [8, [9] [10] [11] [12] [13] C 2 ]-III) clearly demonstrated that C-8, C-9, C-11, and C-12 of myricanol (I) were derived from the C-8 and C-9 atoms of 4-coumaric acid (III). However, in a comparison of the chemical structures of myricanol (I) and 4-coumaric acid (III), the chain structures were apparently different, i.e., myricanol (I) had no unsaturated bond in the molecule. Therefore, it is conceivable that 3-(4-hydroxyphenyl)propionic acid (IV), which has a saturated chain and is the dihydro-analogue for 4-coumaric acid (III), could be a biosynthetic precursor for myricanol (I).
In this article, we reported on whether 3-(4-hydroxyphenyl)propionic acid (IV) was incorporated into myricanol (I). Furthermore, competitive feeding experiments on M. rubra with 13 C-labeled precursors of 4-coumaric acid (III) and 3-(4-hydroxyphenyl)propionic acid (IV) were conducted. Biosynthetic 13 C-NMR studies indicated that 3-(4-hydroxyphenyl)propionic acid (IV) was preferentially employed in the formation of myricanol (I) in M. rubra.
Materials and methods

General
Analytical and preparative thin-layer chromatography (TLC) was performed on silica gel (Merck Kieselgel 60 F 254 ).
1 H-and 13 C-NMR spectra were taken with a JEOL JMM EX-270 spectrometer using tetramethylsilane as an internal standard. Electron impact-mass spectroscopy (EI-MS) analyses were performed with a Shimadzu GCMS-QP 5050 gas chromatograph mass spectrometer. C]triethyl phosphonoacetate (Aldrich; 99 atom% 13 C) by the method as previously described. 12 To a solution of [9- 13 C]coumaric acid ([9-
13
C]-III) (59.4 mg, 0.36 mmol) in methanol (2 ml) and acetic acid (0.1 ml), 10% palladium carbon (100 mg; Wako) was added, and the fl ask was evacuated and then fi lled with hydrogen gas. The resulting solution was stirred at ambient temperature for 60 min. The reaction mixture was fi ltered off and washed with methanol. The fi ltrate was evaporated under reduced pressure, and the residue was purifi ed by TLC 4-[8,9-
C 2 ]Coumaric acid ([8,9-13 C 2 ]-III) was prepared as described previously. 12 Authentic myricanol (I) and myricanone (II) were previously isolated from the branches of M. rubra. 12 Feeding experiment with 3-(4-hydroxyphenyl)-
C]-IV) (4.2 mg (25 μmol) in 1 ml 0.1 % NaOH) was administrated to excised M. rubra young shoots (harvested in October 2006; shoot size, 20-30 cm), which were allowed to metabolize for 2 weeks at room temperature under continuous light. The feeding experiments were duplicated. After incubation, the leaves were removed from the resulting shoots, and stems were frozen, powdered with a pestle and mortar, and extracted with hot MeOH for 12 h. The extracts were partitioned between EtOAc and water. The organic layer was washed with brine, dried over anhydrous Na 2 SO 4 , and evaporated under reduced pressure. The myricanol (I) and myricanone (II) fractions were roughly separated from the extracts by TLC (solvent: ethyl acetate/n-hexane, 1/2), respectively, and analyzed by gas chromatography-mass spectroscopy (GC-MS). Then, the myricanol (I) and myricanone (II) fractions were combined, respectively, and further purifi ed by TLC (solvent: MeOH-CHCl 3 , 2/95). The purifi ed myricanol (I) (∼3 mg) and myricanone (II) (<1 mg) were analyzed by selected ion monitoring (SIM) of DI-MS, respectively.
13 C-NMR analysis of the myricanol (I) was also performed.
Competitive feeding experiment with 4-[8,9- 
Results and discussion
C]-IV) was administered to excised M. rubra young shoots, and it was allowed to metabolize for 2 weeks. The myricanol (I) and myricanone (II) fractions, obtained by TLC separation, were analyzed by GC-MS (data not shown), respectively, and the formation of [ 13 C 2 ]-myricanol (I) and [ 13 C 2 ]-myricanone (II) was determined by comparison with unlabeled authentic compounds. These fractions were further purifi ed by TLC to confi rm the incorporation rate of 13 C carbon into myricanol (I) (Fig. 2B ) and myricanone (II) (Fig. 2E ) using DI-MS with SIM mode. As shown in Table  1 , the results indicated that ∼3% of myricanol (I) and ∼3% of myricanone (II) were biosynthesized from two molecules of 3-(4-hydroxyphenyl)-[1- (Fig. 3B ) displayed enhancement of 13 C resonances at C-9 (δ 22.9) and C-11 (δ 68.6) positions. The magnifi ed fi gures of each heptane-chain carbon (C-7-C-13) in the 13 C-NMR spectra of myricanol (I) are illustrated in Fig. 4 , and the relative integral intensities of the heptane-chain carbons, based on that of C-10, were calculated as shown in Table 2 . The relative intensities of the 13 C-signals were enhanced 3.6 and 3.2 times (i.e., intensity of singlet peak/intensity of naturally occurring singlet peak) for C-9 and C-11, respectively (Fig. 4B) . These results clearly indicated that two molecules of 3-(4-hydroxyphenyl)-[1- We have recently reported that two molecules of 4-coumaric acid (III) were precursors of myricanol (I) and myricanone (II) in M. rubra. 12 In extending our feeding experiments, we have obtained more detailed data indicating that 3-(4-hydroxyphenyl)propionic acid (IV) also behaves as an intermediate. The heptane chain of myricanol (I) is saturated, whereas 4-coumaric acid (IV) has an unsaturated propane chain. Therefore, it is conceivable that 3-(4-hydroxyphenyl)propionic acid (IV), which is the dihydro-analogue for 4-coumaric acid (III), could be a biosynthetic precursor for myricanol (I). C-labeled 3-(4-hydroxyphenyl)propionic acid ([1-13 C]-IV) to examine which is the downstream metabolism precursor for myricanol biosynthesis. The myricanol (I) and myricanone (II) fractions were purifi ed and analyzed by DI-MS (Fig. 2C,F) . As shown in Table 1 , the results proved that 13 C derived from labeled precursor(s) was incorporated into both myricanol (I) and myricanone (II), but the results could not determine which precursor, ([8,9-13 C 2 ]-III) or ([1-
13
C]-IV), was preferentially incorporated into (I) and (II). Consequently, the 13 C-NMR spectrum of myricanol (I) formed by this feeding experiment was measured (Fig. 3C) . C]-IV) were incorporated into myricanol (I). On the other hand, doublet signals were also detected at C-8, C-9, C-11, and C-12; thus, incorporation of two molecules of 4-[8,9-13 C 2 ]coumaric acid ([8,9-13 C 2 ]-III) to myricanol (I) was also confi rmed. However, the incorporation ratios were different. In comparison with the doublet signals of C-9 and C-11, the stronger singlet signals of C-9 and C-11 revealed a higher degree of incorporation of 3-(4-hydroxyphenyl)-[1- Based on the intensities of doublets (i.e., sum of doublet intensities) and singlets (i.e., intensity of singlet peak − intensity of naturally occurring singlet) (see Table 2 ), the incorporation ratios of Table 2 . Relative absorption intensities of heptane-chain carbons signal based on the intensity of C-10 in 13 C-NMR of myricanol (I) isolated from M. rubra
Unlabeled
Isolated after administration of 13 C]propionic acid ([1-13 C]-IV) was administered alone into M. rubra, their incorporation rates into myricanol (I) were relatively similar (3%-6%). Therefore, the present results suggest that direct incorporation of dihydrophenylpropanoid-type precursors into myricanol (I) and the dehydrogenation of a side chain of 4-coumaric acid (III) occurs before the formation of a diarylheptanoid skeleton (Fig. 5) .
Similar results were reported by Kindl and coworkers 13, 14 regarding the biosynthesis of 9,10-dihydrophenanthrenes (stilbenoids) of Orchidaceae. They demonstrated that 3-(3-hydroxyphenyl)propionic acid, as a dihydro-phenylpropanoid precursor, was incorporated into orchinol, and that 3,3′,5-trihydroxybibenzyl, obtained through the operation of bibenzyl synthase, and not stilbene synthase, was an intermediate compound of 9,10-dihydrophenanthrenes. However, the possibility of the interconversion between 4-coumaric acid (III) and 3-(4-hydroxyphneyl)propionic acid (IV) 15 in M. rubra remains to be investigated. In the biosynthesis of diarylheptanoids, the involvement with chalcone synthase-related type III plant polyketide synthase (PKS III) was presumed. 16 Brand et al. 17 reported a new PKS III gene cloned from Wachendorfi a thyrsifl ora, and the enzyme catalyzed the formation of a diketide, which is considered to be a biosynthetic intermediate of phenylphenalenone derivatives. Furthermore, Ramirez-Ahumada et al. 18 detected the activity of curcuminoid synthase in turmeric, which required both 4-coumaroyl-CoA esters and malonyl-CoA for curcuminoid biosynthesis. Katsuyama et al. 19 recently demonstrated the in vitro synthesis of curcuminoids by PKS III from Oryza sativa. Therefore, a similar PKS III might be involved in the biosynthesis of myricanol derivatives in M. rubra. However, in the case of myricanol (I), it is likely that another diphenylheptane synthase, which uses a dihydro-phenylpropanoid precursor as a substrate, could be involved.
Furthermore, the fi ndings that the incorporation ratios of 4-[8,9- C]-IV) differ between C-9 (1:1.6) and C-11 (1:8.4) in myricanol (I) is an interesting result. Myricanol (I) has two different types of aromatic rings; the A-ring has two methoxyl and one phenolic hydroxyl groups, whereas the B-ring has only one phenolic hydroxyl group. If the diarylheptanoid skeleton is built from the same two precursors, for example, 3-(4-hydroxyphenyl)propionyl-CoA, the incorporation ratios at C-9 and C-11 may be indistinguishable as a consequence of symmetry. These results strongly suggest that hydroxylation (and/or methylation) of the A-ring may occur before building of the diarylheptanoid skelton. We are presently attempting to determine whether 13 C-labeled caffeic acid, ferulic acid, dihydro-caffeic acid, and/or dihydro-ferulic acid are incorporated into myricanol (I). 
